Predictors of quality of life in people with Parkinson's disease: Evidence for both domain specific and general relationships

Disability and Rehabilitation

Volumn 36, Issue 23, 2014, Pages 1964-1970

  Simpson, Jane ^a   Lekwuwa, Godwin ^b   Crawford, Trevor ^c  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Health related quality of life; Mental health; Parkinson's disease; Positive functioning

Indexed keywords

ADAPTATION; ADAPTIVE BEHAVIOR; AGED; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; FEMALE; HUMAN; MALE; MENTAL HEALTH; MIDDLE AGED; PARKINSON DISEASE; PREDICTIVE VALUE; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SELF HELP; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PHYSIOLOGICAL; ADAPTATION, PSYCHOLOGICAL; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; SELF-HELP GROUPS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84911982676     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638288.2014.883442     Document Type: Article

References (67)

1. Guyatt G, Feeny D, Patrick D. Measuring health-related quality of life. Ann Intern Med 1993;22:622-9.
2. Martinez-Martin P, Jeukens-Visser M, Lyons K, et al. Health-related quality-of-life scales in Parkinson's disease: Critique and recommendations. Movement Disord 2011;26:2371-80.
3. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well-being for individuals with Parkinson's disease. Qual Life Res 1995;4:241-8.
4. Huang T, Wang B, Chen K. Quality of life in parkinson's disease patients: Validation of the short-form eight-item Parkinson's disease questionnaire (PDQ-8) in Taiwan. Qual Life Res 2011;20:499-505.
5. Katsarou Z, Bostantjopoulou S, Peto V, et al. Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39). Qual Life Res 2001; 10:159-63.
6. Kwon D, Kim J, Ma H, et al. Translation and validation of the Korean version of the 39-item Parkinson's disease questionnaire. J Clin Neurol 2013;9:26-31.
7. Martinez-Martin P, Gunther D. Effect of medical and surgical interventions on health-related quality of life in Parkinson's disease. Movement Disord 2007;22:757-65.
8. Daniels C, Krack P, Volkmann J, et al. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?. Movement Disord 2011;26:2516-21.
9. de Dreu M, van der Wilk A, Poppe E, et al. Rehabilitation, exercise therapy and music in patients with Parkinson's disease: A metaanalysis of the effects of music-based movement therapy on walking ability, balance and quality of life. Parkinson Relat Disord 2012;18: 114-19.
10. Ehab G, Barsnley S, Chellappa R. Effect of physical exercisemovement strategies programme on mobility falls and quality of life in Parkinson's disease. Int J Therap Rehabil 2012;19:88-96.
11. Martinez-Martin P, Kurtis M. Systematic review of the effect of dopamine receptor agonists on patient health-related quality of life. Parkinson Relat Disord 2010;15:58-64.
12. Soh S-E, Morris M, McGinley J. Determinants of health-related quality of life in Parkinson's disease: A systematic review. Parkinson Relat Disord 2011;17:1-9.
13. Forjaz MJ, Frades-Payo B, Martinez-Martin P. The current state of the art concerning quality of life in Parkinson's disease: II. Determining and associated factors. Revista de Neurologia 2009;49: 655-60.
14. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri K. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Movement Disord 2011;26: 399-406.
15. Post B, Muslimovic D, van Geloven N, et al. Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease. Movement Disord 2011;26: 449-56.
16. Winter Y, von Campenhausen S, Popov G, et al. Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study. Parkinson Relat Disord 2010;16:243-8.
17. Klepac N, Trkulja V, Relja M, Babic T. Is quality of life in nondemented Parkinson's disease patients related to cognitive performance?. A clinic-based cross-sectional study. Eur J Neurol: The Official Journal of the European Federation of Neurological Societies 2008;15:128-33.
18. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease?. J Neurol Neurosurg Psychiatr 2000;69:308-12.
19. GPDSC. Factors impacting on quality of life in Parkinson's disease: Results from an international survey. Movement Disord 2002;17: 60-7.
20. Chapuis S, Ouchchane L, Metz O, et al. Impact of the motor complications of Parkinson's disease on the quality of life. Movement Disord 2005;20:224-30.
21. Ellis T, Cavanaugh J, Earhart G, et al. Which measures of physical function and motor impairment best infuence quality of life in Parkinson's disease?. Parkinson Relat Disord 2011;17:693-7.
22. Chrischilles E, Rubenstein L, Voelker M, et al. Linking clinical variables to health-related quality of life in Parkinson's disease. Parkinson Relat Disord 2002;8:199-209.
23. Abudi S, Bar-Tal Y, Ziv L, Fish M. Parkinson's disease symptoms-'patients' perceptions. J Adv Nurs 1997;25:54-9.
24. Hinnell C, Hurt C, Landau S, et al. Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?. Movement Disord 2012;27:236-41.
25. Zhao Y, Tan L, Lau P, et al. Factors affecting health-related quality of life amongst Asian patients with Parkinson's disease. Eur J Neurol: The Official Journal of the European Federation of Neurological Societies 2008;15:737-42.
26. Leroi I, Ahearn D, Andrews M, et al. Behavioural disorders, disability and quality of life in Parkinson's disease. Age Ageing 2011;40:614-21.
27. Robottom B, Gruber-Baldini A, Anderson K, et al. What determines resilience in patients with Parkinson's disease?. Parkinson Relat Disord 2012;18:174-7.
28. Soh S, McGinley J, Watts J, et al. Determinants of health-related quality of life in people with Parkinson's disease: A path analysis. Qual Life Res 2013;22:1543-53.
29. Keeling M, Bamborough J, Simpson J. Depression, anxiety and positive affect in people diagnosed with low grade tumours: The role of illness perceptions. Psycho-Oncol 2013;22:1421-7.
30. Rahman S, Griffin H, Quinn N, Jahanshahi M. On the nature of fear of falling in Parkinson's disease. Behav Neurol 2011;24:219-28.
31. Dubayova T, Nagyova I, Havlikova E, et al. The association of type D personality with quality of life in patients with Parkinson's disease. Aging Mental Health 2009;13:905-12.
32. Scalzo P, Flores C, Marques J, et al. Impact of changes in balance and walking capacity on the quality of life in patients with Parkinson's disease. Arquivos de Neuro-Psiquiatria 2012;70:119-24.
33. Hoehn M, Yahr M. Parkinsonism: Onset, progression and mortality. Neurology 1967;17:427-42.
34. Karlsen K, Larsen J, Tandberg E, Maeland J. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatr 1999;66:431-43.
35. Barak Y, Achiron A. Happiness and neurological disease. Exp Rev Neurotherapeut 2009;9:445-59.
36. McCarthy B, Brown R. Psychosocial factors in Parkinson's disease. Br J Clin Psychol 1989;28:41-52.
37. Ridder D, Schreurs K, Bensing J. The relative benefits of being optimistic: Optimism as a coping resource in multiple sclerosis and Parkinson's disease. Br J Health Psychol 2000;5:141-55.
38. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
39. Dobson C. Conducting research with people not having the capacity to consent to participation; 2008. Available from: Http://www.psy. ed.ac.uk/psy-research/documents/BPS%20Guidelines%20for%20 Conducting%20Research%20with%20People%20not%20having%20Capacity%20to%20Consent.pdf [last accessed 24 Jan 2014].
40. HMSO. Mental Capacity Act 2005. London: The Stationery Office; 2005.
41. Fahn S, Elton R. Unified Parkinson's disease rating scale. In: Fahn S, Marsden C, Goldstein M, Calne D, eds. Recent developments in Parkinson's disease. New Jersey: Macmillan Healthcare Information; 1987:153-63.
42. Hobson J, Edwards N, Meara R. The Parkinson's disease activities of daily living scale: A new simple and brief subjective measure of disability in Parkinson's disease. Clin Rehabil 2001;15:241-6.
43. Lovibond S, Lovibond PF. Manual for the Depression Anxiety Stress Scales. Sydney: Psychology Foundation of Australia; 1996.
44. Crawford JR, Henry JD. The Depression Anxiety Stress Scales (DASS): Normative data and latent structure in a large non-clinical sample. Br J Clin Psychol 2003;42:111-31.
45. Simpson J, Haines K, Lekwuwa G, et al. Social support and psychological outcome in people with Parkinson's disease: Evidence for a specific pattern of associations. Br J Clin Psychol 2006;45: 585-90.
46. Scheier MF, Carver CS. Effects of optimism on psychological and physical well-being: Theoretical overview and empirical update. Cogn Therap Res 1992;16:201-28.
47. Shifren K. Individual differences in the perception of optimism and disease severity: A study among individuals with Parkinson's disease. J Behav Med 1996;19:241-71.
48. Rosenburg M. Society and the adolescent self-image. Princeton (NJ): Princeton University Press; 1965.
49. Schmitt DP, Allik J. Simultaneous administration of the Rosenberg Self-Esteem Scale in 53 nations: Exploring the universal and culturespecific features of global self-esteem. J Person Soc Psychol 2005; 89:623-42.
50. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Person Soc Psychol 1988;54:1063-70.
51. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The PDQ-8: Development and validation of a short-form Parkinson's disease questionnaire. Psychol Health 1997;12:805-14.
52. IBM Corp R. IBM SPSS Statistics for Windows, Version 19.0. Armonk (NY): IBM Corp.; 2010.
53. Brod M, Mendelsohn GA, Roberts B. Patients' experiences of Parkinson's disease. J Gerontol Series B: Psychol Sci Soc Sci 1998; 53:213-22.
54. Edgar K, Skinner T. Illness representations and coping as predictors of emotional well-being in adolescents with type 1 diabetes. J Pediatr Psychol 2003;28:485-93.
55. Field A. Discovering statistics using SPSS, 3rd ed. London: Sage; 2010.
56. Wegelin J, McNamara P, Durso R, et al. Correlates of excessive daytime sleepiness in Parkinson's disease. Parkinson Relat Disord 2005;11:441-8.
57. Simpson J, McMillan H, Reeve D. Reformulating psychological difficulties in people with Parkinson's disease: The potential of a social relational approach to disablism. Parkinson's Dis 2013; 2013:608562. doi: 10.1155/2013/608562.
58. Hoops S, Nazem S, Siderowf A, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009;73:1738-45.
59. Hagell P, Nygren C. The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: Implications for evidence based medicine. J Neurol, Neurosurg Psychiatr 2007;78:1191-8.
60. Weintraub D, Morales KH, Moberg PJ, et al. Antidepressant studies in Parkinson's disease: A review and meta-Analysis. Movement Disord 2005;20:1161-9.
61. Dobkin RD, Allen LA, Menza M. Cognitive-behavioral therapy for depression in Parkinson's disease: A pilot study. Movement Disord 2007;22:946-52.
62. Marras C, McDermott MP, Rochon PA, et al. Predictors of deterioration in health-related quality of life in Parkinson's disease: Results from the DATATOP trial. Movement Disord 2008;23:653-9.
63. Oehlberg K, Barg FK, Brown GK, et al. Attitudes regarding the etiology and treatment of depression in Parkinson's disease: A qualitative study. J Geriatr Psychiatr Neurol 2008;21:123-32.
64. Fitzpatrick L, Simpson J, Smith A. A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson's disease. Psychol Psychother: Theory Res Pract 2010;83:179-92.
65. Charidimou A, Seamons J, Selai C, Schrag A. The role of cognitivebehavioural therapy for patients with depression in Parkinson's disease. Parkinson's Dis 2011;2011:Article ID 737523.
66. Dobkin RD, Menza M, Allen LA, et al. Cognitive behavior therapy for depression in Parkinson's disease: A randomized controlled trial. Am J Psychiatr 2011;168:1066-74.
67. Delaney M, Leroi I, Simpson J, Overton PG. Impulse control disorders in Parkinson's disease: A psychosocial perspective. J Clin Psychol Med Settings 2012;19:338-46.